Spotlight: Abzyme Awarded NIH Phase II SBIR Grant for Developing Multi-specific Long-acting Antibodies for Treatment of Retinal Neovascular Diseases
Royersford, PA, March 01, 2024. Retinal neovascular diseases including neovascular age-related macular degeneration (AMD), diabetic macular edema, and retinal vein occlusion are the most vision-threatening diseases among the developed world working-age population....
Exciting Opportunities in Preclinical Genomic Business Development!
Thrilled to share that our customer, a market leader in the genomic services sector, is on the lookout for dynamic individuals to join their team as Preclinical Genomic Business Development Executives or Remote Inside Sales Representatives. These newly created...
Making the Most of your Scientific Tradeshows
In this webinar, Laura Haldane will be joined by Steve Manobianco, Managing Director at PSG Life Sciences, Leticia Manosso, Demand Generation & Campaign Manager at Visiopharm and Janneta Tabakov, Senior Manager, Marketing at Arima Genomics. They will be sharing...
PSG Life Sciences Achieves HubSpot Gold Partner Status
PSG Life Sciences Achieves HubSpot Gold Partner Status [Princeton, July 14, 2023] – PSG Life Sciences, a leading provider of innovative marketing, business development, and sales solutions for the life sciences industry, is proud to announce that it has achieved the...
Introducing Brady Millican to the PSG Life Sciences Team
May 11, 2023 Princeton New Jersey – Brady Millican, a seasoned professional with over 30 years of experience in the clinical diagnostic and CDMO industry, has joined PSG Life Sciences, the leader in fractional life sciences commercialization services, as the new...